Literature DB >> 15337524

Protein tyrosine kinase Syk modulates EGFR signalling in human mammary epithelial cells.

Anja Ruschel1, Axel Ullrich.   

Abstract

Signalling through protein tyrosine kinases (PTKs) is critical in the regulation of important cellular processes and its deregulation is associated with pathophysiological disorders such as cancer. We investigated the function of the PTK spleen tyrosine kinase (Syk) in the regulation of growth factor signalling pathways in human mammary epithelial cells. Our results show that downregulation of endogenous Syk expression enhances the ligand-induced activity of the epidermal growth factor receptor (EGFR) but not that of the closely related human epidermal growth factor receptor 2 (HER2) and human epidermal growth factor receptor 3 (HER3) receptors. Moreover, Syk function interfered with EGFR-mediated cell responses such as proliferation and survival of mammary epithelial cells. A mechanistic link between Syk and EGFR is further supported by the colocalisation of the two PTKs in membrane fractions as well as the regulatory feedback effects of the EGFR kinase on Syk activity. Our findings demonstrate that Syk acts a negative control element of EGFR signalling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337524     DOI: 10.1016/j.cellsig.2004.03.007

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  11 in total

1.  Differential expression of spleen tyrosine kinase Syk isoforms in tissues: Effects of the microbial flora.

Authors:  Florentina Duta; Marina Ulanova; Daniel Seidel; Lakshmi Puttagunta; Sorin Musat-Marcu; Kevin S Harrod; Alan D Schreiber; Ulrich Steinhoff; A Dean Befus
Journal:  Histochem Cell Biol       Date:  2006-05-18       Impact factor: 4.304

2.  Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling.

Authors:  Veena Sangkhae; Sebastian Jonas Saur; Alexis Kaushansky; Kenneth Kaushansky; Ian Stuart Hitchcock
Journal:  Exp Hematol       Date:  2014-03-04       Impact factor: 3.084

3.  Transcription repressor activity of spleen tyrosine kinase mediates breast tumor suppression.

Authors:  Lei Wang; Eswaran Devarajan; Jin He; Sekhar P Reddy; Jia Le Dai
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

4.  Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion.

Authors:  Tracy Layton; Cristel Stalens; Felizza Gunderson; Steve Goodison; Steve Silletti
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

5.  A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis.

Authors:  Cheryl Eifert; Xianhui Wang; Leila Kokabee; Antonis Kourtidis; Ritu Jain; Michael J Gerdes; Douglas S Conklin
Journal:  Genes Chromosomes Cancer       Date:  2013-08-03       Impact factor: 5.006

Review 6.  The extracellular matrix as an adhesion checkpoint for mammary epithelial function.

Authors:  Elad Katz; Charles H Streuli
Journal:  Int J Biochem Cell Biol       Date:  2006-11-23       Impact factor: 5.085

7.  Erk2 but not Erk1 regulates crosstalk between Met and EGFR in squamous cell carcinoma cell lines.

Authors:  Simone Gusenbauer; Emanuele Zanucco; Pjotr Knyazev; Axel Ullrich
Journal:  Mol Cancer       Date:  2015-03-04       Impact factor: 27.401

Review 8.  Multi-PK antibodies: Powerful analytical tools to explore the protein kinase world.

Authors:  Yasunori Sugiyama; Isamu Kameshita
Journal:  Biochem Biophys Rep       Date:  2017-06-22

9.  Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo.

Authors:  You Me Sung; Xuehua Xu; Junfeng Sun; Duane Mueller; Kinza Sentissi; Peter Johnson; Elana Urbach; Françoise Seillier-Moiseiwitsch; Michael D Johnson; Susette C Mueller
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

10.  SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.

Authors:  Jan Blancato; Ashley Graves; Banafsheh Rashidi; Maria Moroni; Leopold Tchobe; Metin Ozdemirli; Bhaskar Kallakury; Kepher H Makambi; Catalin Marian; Susette C Mueller
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.